Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Attitudes toward menstruation in females with schizophrenia or schizoaffective disorders in Taiwan.

Liang HY, Lee LW, Kelsen BA, Hsu SC, Liu CY, Chen CY.

Climacteric. 2013 Dec;16(6):682-8. doi: 10.3109/13697137.2012.753872. Epub 2012 Dec 31.

PMID:
23205628
2.

Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C.

Arch Gen Psychiatry. 2005 Jul;62(7):717-24.

PMID:
15997012
3.
4.

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC.

J Clin Psychiatry. 2004 Oct;65(10):1372-6.

PMID:
15491241
5.

[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].

Misdrahi D, Delgado A, Bouju S, Comet D, Chiariny JF.

Encephale. 2013 May;39 Suppl 1:S8-14. doi: 10.1016/j.encep.2012.03.005. Epub 2013 Mar 28. French.

PMID:
23541914
6.

Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study.

Lerner V, Miodownik C, Kaptsan A, Cohen H, Loewenthal U, Kotler M.

J Clin Psychiatry. 2002 Jan;63(1):54-8.

PMID:
11838627
7.

Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.

de Bartolomeis A, Balletta R, Giordano S, Buonaguro EF, Latte G, Iasevoli F.

Psychiatry Res. 2013 Dec 15;210(2):387-95. doi: 10.1016/j.psychres.2013.06.042. Epub 2013 Jul 30.

PMID:
23910239
8.

Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.

Kwon JS, Jang JH, Kang DH, Yoo SY, Kim YK, Cho SJ; APLUS study group.

Psychiatry Clin Neurosci. 2009 Feb;63(1):73-81. doi: 10.1111/j.1440-1819.2008.01907.x.

9.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
10.

The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.

Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S.

J Clin Psychiatry. 2009 Jan;70(1):25-35. Epub 2008 Dec 2.

PMID:
19192472
11.

Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.

Andreou C, Roesch-Ely D, Veckenstedt R, Bohn F, Aghotor J, Köther U, Pfueller U, Moritz S.

Psychiatry Res. 2013 Dec 30;210(3):729-34. doi: 10.1016/j.psychres.2013.08.019. Epub 2013 Aug 30.

PMID:
23998362
12.

Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.

Vassileva IV, Milanova VK.

Folia Med (Plovdiv). 2012 Oct-Dec;54(4):62-8.

PMID:
23441471
13.

Attitudes of patients with schizophrenia toward placebo-controlled clinical trials.

Hummer M, Holzmeister R, Kemmler G, Eder U, Hofer A, Kurzthaler I, Oehl M, Weiss E, Fleischhacker WW.

J Clin Psychiatry. 2003 Mar;64(3):277-81.

PMID:
12716268
14.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
15.
16.

Item response analysis of the Positive and Negative Syndrome Scale.

Santor DA, Ascher-Svanum H, Lindenmayer JP, Obenchain RL.

BMC Psychiatry. 2007 Nov 15;7:66.

17.

Ambivalent sexism, attitudes towards menstruation and menstrual cycle-related symptoms.

Marván ML, Vázquez-Toboada R, Chrisler JC.

Int J Psychol. 2014 Aug;49(4):280-7. doi: 10.1002/ijop.12028. Epub 2013 Nov 20.

PMID:
24990639
18.

Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.

Baloush-Kleinman V, Levine SZ, Roe D, Shnitt D, Weizman A, Poyurovsky M.

Schizophr Res. 2011 Aug;130(1-3):176-81. doi: 10.1016/j.schres.2011.04.030. Epub 2011 Jun 1. Erratum in: Schizophr Res.2013 May;146(1-3):379.

PMID:
21636254
19.

Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA.

Schizophr Bull. 2009 Mar;35(2):336-46. doi: 10.1093/schbul/sbn067. Epub 2008 Jun 26.

20.

How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.

Beck EM, Cavelti M, Wirtz M, Kossowsky J, Vauth R.

Psychiatry Res. 2011 May 15;187(1-2):55-61. doi: 10.1016/j.psychres.2010.10.012. Epub 2010 Nov 12.

PMID:
21074860
Items per page

Supplemental Content

Write to the Help Desk